Concomitant Drug Interactions With Non–Vitamin K Oral Anticoagulants Are Associated With Bleeding and Mortality Risk in Patients With Nonvalvular Atrial Fibrillation

Chun‐Ka Wong; Yuen‐Kwun Wong; Yap‐Hang Chan; Mei-Yi Lin; Jo Jo Hai; Kai‐Hang Yiu; Professor Gregory Lip; Kui Kai Lau; Hung‐Fat Tse

doi:10.1161/jaha.124.038668

Back

Shared by

Professor Gregory Lip

University of Liverpool

Concomitant Drug Interactions With Non–Vitamin K Oral Anticoagulants Are Associated With Bleeding and Mortality Risk in Patients With Nonvalvular Atrial Fibrillation

Article 2025 en

Authors

CW
Chun‐Ka Wong
YW
Yuen‐Kwun Wong
YC
Yap‐Hang Chan

Abstract

1 min read

For patients with nonvalvular atrial fibrillation taking non-vitamin K oral anticoagulants, several concurrent medications were associated with increased risks of intracranial hemorrhage, major bleeding hospitalizations, and overall mortality.

Related publications

Article2019

Effectiveness and Safety of Contemporary Oral Anticoagulants Among Asians With Nonvalvular Atrial Fibrillation

So-Ryoung Lee, Eue-Keun Choi, Soonil Kwon, Kyungdo Han, Jin‐Hyung Jung, Myung‐Jin Cha, Seil Oh, Professor Gregory Lip

Article2019

Non–Vitamin K Antagonist Oral Anticoagulants in Asian Patients With Supranormal Renal Function

Seil Oh, Professor Gregory Lip, So-Ryoung Lee, Eue-Keun Choi, Kyungdo Han, Jin‐Hyung Jung, Myung‐Jin Cha

Article2021

Effectiveness and safety of non-vitamin K antagonist oral anticoagulants versus warfarin among nonvalvular atrial fibrillation patients with prior bleeding events

Professor Gregory Lip, Allison Keshishian, A Kang, X Luo, Nipun Atreja, Y Zhang, Patricia Schuler, Jenny Jiang, K Lovett, Hüseyin Yüce, Steven Deitelzweig

Article2019

P4780Effectiveness and safety of non-vitamin k antagonist oral anticoagulants in patients with atrial fibrillation and valvular heart disease

Inki Moon, S R Lee, Eunsuk Choi, E J Lee, Jin‐Hyung Jung, Kyungdo Han, M J, Seil Oh, Professor Gregory Lip

Article2018

Data on incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants

Daniele Pastori, Professor Gregory Lip, Alessio Farcomeni, Francesco Del Sole, Angela Sciacqua, Francesco Perticone, Rossella Marcucci, Elisa Grifoni, Pasquale Pignatelli, Francesco Violi, Mirella Saliola, Marco Casciaro, Danilo Menichelli, Francesco Cribari, Alberto Paladino, Rony Gingis, Marta Novo, Vittoria Cammisotto, Cristina Nocella, Simona Bartimoccia, Roberto Carnevale,

Concomitant Drug Interactions With Non–Vitamin K Oral Anticoagulants Are Associated With Bleeding and Mortality Risk in Patients With Nonvalvular Atrial Fibrillation

Abstract

Discussion(0)

Related publications

Effectiveness and Safety of Contemporary Oral Anticoagulants Among Asians With Nonvalvular Atrial Fibrillation

Non–Vitamin K Antagonist Oral Anticoagulants in Asian Patients With Supranormal Renal Function

Effectiveness and safety of non-vitamin K antagonist oral anticoagulants versus warfarin among nonvalvular atrial fibrillation patients with prior bleeding events

P4780Effectiveness and safety of non-vitamin k antagonist oral anticoagulants in patients with atrial fibrillation and valvular heart disease

Data on incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants